Pharmaceutical and biomedical potential of PEGylated dendrimers

Current Pharmaceutical Design

Volumn 13, Issue 4, 2007, Pages 415-429

  Gajbhiye, Virendra ^a   Kumar, P Vijayaraj ^a   Tekade, Rakesh Kumar ^a   Jain, N K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Cytotoxity; Dendrimer; Drug delivery; Gene delivery; MRI contrast agents; PEGylation; Solubilization; Targeting

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; ARTEMETHER; BETAMETHASONE DERIVATIVE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CITRIC ACID; CONTRAST MEDIUM; DENDRIMER; DICLOFENAC; DOXORUBICIN; FLUOROURACIL; INDOMETACIN; LIPOSOME; LYSINE; MACROGOL; MEFENAMIC ACID; MESALAZINE; MESYLIC ACID; METHOTREXATE; NANOCARRIER; PACLITAXEL; PENICILLIN V; PLASMID DNA; POLYAMIDOAMINE; POLYESTER; PYRENE; PYRIDINE; RIFAMPICIN; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; BLOOD TOXICITY; CELL SHAPE; CELL SIZE; CYTOTOXICITY; DENDRITIC CELL; DNA TRANSFECTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; GENETIC TRANSFECTION; HUMAN; HYDROPHOBICITY; IMMUNOASSAY; IMMUNOGENICITY; MEDICAL TECHNOLOGY; MICELLE; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; STRUCTURE ANALYSIS; VIRAL GENE DELIVERY SYSTEM;

EID: 33947596482     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207780162999     Document Type: Review

References (144)

1. Aulenta F, Hayes W, Rannard S. Dendrimers: a new class of nanoscopic containers and delivery devices. Eur Polym J 2003; 39: 1741-71.
2. Stiriba SE, Frey H, Haag R. Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. Angew Chem Int Ed Engl 2002; 41: 1329-34.
3. Patri AK, Istvan J, Majoros, James R, Baker Jr. Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol 2002; 6: 466-71.
4. Boas U, Heegaard PMH. Dendrimers in drug research. Chem Soc Rev 2004; 33: 43-63.
5. Tomalia DA, Naylor AM, Goddard WA III. Starburst Dendrimers: Molecular-Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter. Angew Chem Int Ed Engl 1990; 29: 138-75.
6. 125I-labeled polyamidoamine dendrimers in vivo. J Control Release 2000; 65: 133-48.
7. Jevprasesphant R, Penny J, Jalal R, Attwood D, Mckeown NB, D'Emanuele A. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharma 2002; 252: 263-6.
8. Hawker CJ, Frechet JMJ. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J Am Chem Soc 1990; 112: 7638-47.
9. Liu M, Kono K, Frechet JMJ. Water-soluble unimolecular micelles: their potential as drug delivery agents. J Control Release 2000; 65: 121-31.
10. Liu M, Kono K, Frechet JMJ. Water-soluble dendrimer-polyethylene glycol starlike conjugates as potential drug carriers. J Polym Sci A 1999; 37: 3492-503.
11. Pepas NA, Keys KB, Torres-Lugo M, Lowman AM, Poly(ethyleneglycol)-containing hydrogels in drug delivery. J Control Release 1999; 62: 81-7.
12. Harris JM, Kozlowski A, Bentley MD, J Macromol Sci Rev Macromole Chem Phys 1984: 25: 325-73.
13. Zalipsky S. Chemistry of polyethylene glycol conjugates with biologically active molecules. Adv Drug Del Rev 1995; 16: 157-82.
14. Liu M, Fréchet JMJ. Designing dendrimers for drug delivery. Pharm Sci Technol Today 1999; 2: 393-401.
15. Bhadra D, Bhadra S, Jain S, Jain NK. A PEGylated dendritic nanaparticulate carrier of fluorouracil. Int J Pharm 2003; 257: 111-24.
16. Petersen H, Fechner PM, Fischer D, Kissel T. Synthesis, characterization, and biocompatibility of polyethylenimine-graftpoly(ethylene glycol) block copolymers. Macromolecules 2002; 35: 6867-74.
17. Namazi H, Adeli M. Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. Biomaterials 2005; 26: 1175-83.
18. Tansey W, Ke S, Cao X-Y, Marites J. Pasuelo, Wallace S, Li C. Synthesis and characterization of branched poly(L-glutamic acid) as a biodegradable drug carrier. J Control Release 2004; 94: 39-51.
19. Sideratou Z, Tsiourvas D, Paleos CM. Solubilization and release properties of PEGylated diaminobutane poly(propylene imine) dendrimers. J Colloid Int Sci 2001; 242: 272-6.
20. Kojima C, Kono K, Maruyama K, Takagishi T. Synthesis of Poly amidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconj Chem 2000; 11: 910-7.
21. Mannisto M, Vanderkerken S, Toncheve V, Elomaa M, Ruponen, Schacht E, et al. Structure-activity relationships of Poly(L-lysine): effects of PEGylation and molecular shape on physiochemical and biological properties in gene delivery. J Control Release 2002; 83:169-82.
22. Gupta U, Agashe HB, Asthana A, Jain NK. Dendrimers: novel polymeric nanoarchitecture for solubility enhancement. Biomacromolecules 2006; 7: 649-58.
23. Bhadra D, Bhadra S, Jain P, Jain NK. Pegnology: a review of PEGylated systems. Pharmazie 2002; 57: 5-29.
24. Khopade AJ, Caruso F, Tripathi P, Nagaich S, Jain NK. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int J Pharm 2002; 232: 157-62.
25. Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Del Rev 2005; 57: 2214-37.
26. Frey H, Haag R. Dendritic polyglycerol: a new versatile biocompatible material. Rev Mole Biotech 2002; 90: 257-67.
27. Patri AK, Kukowska-Lotallo JF, Baker JR Jr. Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Del Rev 2005; 57: 2203-14.
28. Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflection on the field. Ad Drug Deli Rev 2005; 57: 2106-29.
29. Gillies ER, Frechet JMJ. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 2005; 10: 35-43.
30. Dennig J, Duncan E. Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers. Rev Mole Biotech 2002; 90: 339-47.
31. Borges AR, Schengrund CL. Dendrimers and antivirals: A review. Curr Drug Targets Infect Disord 2005; 5: 247-54.
32. Okuda T, Kawakami S, Maeie T, Niidome T, Yamashita F, Hashida M. Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration. J Control Release 2006; 114: 69-77.
33. Margerum LD, Campion BK, Koo M, Shargill N, Lai JJ, Marumoto A, et al. Gadolinium(III) D03A macrocycles and polyethylene glycol coupled to dendrimers, Effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents. J Alloys Compd 1997; 249: 185-90.
34. Stevelmans S, Hest van JCM, Jansen JFGA, Boxtel van DAFJ, Brabander-van den B de EMM, Meijer EW, et al. Synthesis, characterization and guest-host properties of inverted unimolecular dendritic micelles. J Am Chem Soc 1996; 118: 7398-9.
35. Bhadra D, Bhadra S, Jain NK. PEGylated peptide-based dendritic nanoparticulate systems for delivery of artemether. J Drug Del Sci Tech 2005; 15: 65-73
36. Berna M, Dalzoppo D, Pasut G, Manunta M, Izzo L, Jones AT, et al. Novel Monodisperse PEG-Dendrons as New Tools for Targeted Drug Delivery: Synthesis, Characterization and Cellular Uptake. Biomacromolecules 2006; 7: 146-53.
37. Ooya T, Lee J, Park K. Effects of ethylene glycol-based graft, starshaped, and dendritic polymers on solubilization and controlled release of paclitaxel. J Control Release 2003; 93: 121-7.
38. Gitsov I, Frechet JMJ, Stimuli-Responsive Hybrid Macromolecules: Novel Amphiphilic Star Copolymers with Dendritic Groups at the Periphery. J Am Chem Soc 1996; 118: 3785-6.
39. Yang Hu, Lopina ST. Penicillin V-conjugated PEG-PAMAM star polymers. J Biomater Sci Polymer Edn 2003; 14: 1043-56.
40. Qualmann B, Kessels MM, Musiol HJ, Sierralta WD, Jungblut PW, Moroder L. Synthesis of boron rich lysine dendrimer as protein labels in electron microscopy. Angew Chem Int Ed Engl 1996; 35: 909-11.
41. Heldt JM, Durand NF, Salmain M, Vessieres A, Jaouen G, Preparation and characterization of poly(amidoamine) dendrimers functionalized with a rhenium carbonyl complex and PEG as new IR probes for carbonyl metallo immunoassay. J Organometallic Chem 2004; 689: 4775-82.
42. Roberts JC, Bhalgat MK, Zera RT. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res 1996; 30: 53-65.
43. Chen HT, Neerman MF, Parrish AR, Simanek E. Cytotoxicity, haemolysis, and acute in vivo toxicity of dendrimer based on melamine, candidate vehicles for drug delivery. J Am Chem Soc 2004; 126: 10044-8.
44. Zinselmeyer BH, Mackay SP, Schatzlein AG, Uchegbu IF. The lower generation polypropyleneimine dendrimers are effective gene transfer agents. Pharma Res 2002; 19: 960-7.
45. Padilla OL de Jesus, Ihre H, Gagne L, Frechet JMJ, Szoka FC J. Polyester dendritic system for drug delivery application: in vitro and in vivo evaluation. Bioconjug Chem 2002; 13: 453-61.
46. Roller S, Turk H, Stumbe JF, Rapp W, Haag R. Polystyrene-graft-polyglycerol resins: a new type of high-loading hybrid support for organic synthesis. J Comb Chem 2006; 8: 350-4.
47. Siegers C, Biesalski M, Haag R. Self-assembled monolayers of dendritic polyglycerol derivatives on gold that resist the adsorption of proteins. Chemistry 2004; 10: 2831-8.
48. Turk H, Haag R, Alban S. Dendritic sulfates as new heparin analogues and potent inhibitors of the complement system. Bioconjug Chem 2004; 15: 162-7.
49. Nad S, Roller S, Haag R, Breinbauer R. Electrolysis as an efficient key step in the homogeneous polymer-supported synthesis of Nsubstituted pyrroles. Org Lett 2006; 8: 403-6.
50. Koc F, Wyszogrodzka M, Eilbracht P, Haag R. Highly regioselective synthesis of amino-functionalized dendritic polyglycerols by a one-pot hydroformylation/reductive amination sequence. J Org Chem 2005; 70: 2021-5.
51. Roller S, Zhou H, Haag R. High-loading polyglycerol supported reagents for Mitsunobu- and acylation-reactions and other useful polyglycerol derivatives. Mol Divers 2005; 9: 305-16.
52. Hawker CJ, Wooley KL, Frechet JMJ. Unimolecular micelles and globular amphiphiles dendritic macromolecules as novel recyclable solubilization agents. J Chem Soc Perkin Trans 1993; 1: 1287-97.
53. Beezer AE, King ASH, Martin IK, Mitchel JC, Twyman LJ, Wain CF. Dendrimers as potential drug carrier, encapsulation of acidic hydrophobies within water soluble PAMAM derivatives. Tetrahedron Lett 2003; 59: 3873-80.
54. Devarakonda B, Hill RA, DeVilliers MM. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm 2004; 284: 133-40
55. Asthana A, Chauhan AS, Diwan PV, Jain NK. Poly(amidoamine) (PAMAM) Dendritic Nanostructures for Controlled Sitespecific Delivery of Acidic Anti-inflammatory Active Ingredient. AAPS PharmSciTech 2005; 6: 536-42.
56. Newkome GR, Yao Z, Baker GR, Gupta VK. Micelles. Part 1, Cascade molecules, a new approach to micelles, A (27)-arborol. J Org Chem 1985; 50: 2003-4.
57. Pan Y, Ford WT. Amphiphilic Dendrimers with Both Octyl and Triethylenoxy Methyl Ether Chain Ends. Macromolecules 2000; 33: 3731-38.
58. British Pharmacopoeia 2000; 203.
59. Yang H, Morris JJ, Lopina ST. Polyethylene glycol-polyamidoamine dendritic micelle as solubility enhancer and the effect of the length of polyethylene glycol arms on the solubility of pyrene in water. J Colloid Int Sci 2004; 273: 148-54.
60. Dandliker PJ, Diederich F, Gisselbrect JPCB, Louati A, Gross M. Water soluble dendritic iron porphyrins, synthetic models of globular heme proteins. Angew Chem Int Ed Engl 1995; 34: 2725-8.
61. Haensler J, Szoka FC. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem 1993; 4: 372-9.
62. Luo D, Haverstick K, Belcheva N, Han E, Saltzman WM. Poly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA Delivery. Macromolecules 2002; 35: 3456-62.
63. Crooke ST. An overview of progress in antisense therapeutics. Antisense Nucleic Acid Drug Dev 1998; 8:115-22.
64. Stull RA Jr, Szoka FC Jr. Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects. Pharm Res 1995; 12: 465-83.
65. Patil SD, Burgess DJ. DNA-based Biopharmaceuticals: therapeutics for the 21st Century. AAPS Newsmagazine 2003; 6: 27.
66. Patil SD, Rhodes DG, Burgess DJ. DNA-based Therapeutics and DNA Delivery Systems: A Comprehensive Review. AAPS J 2005; 07: E61-E77.
67. Kamiya H, Tsuchiya H, Yamazaki J, Harashima H. Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv Drug Deliv Rev 2001; 52: 153-64.
68. Borchard G. Chitosans for gene delivery. Adv Drug Deliv Rev 2001; 52: 145-50.
69. Lemkine GF, Demeneix BA. Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther 2001; 3: 178-82.
70. Lollo CP, Banaszczyk MG, Mullen PM, Coffin CC, Wu D, Carlo AT, et al. Poly-L-lysine-based gene delivery systems: synthesis, purification, and application. Methods Mol Med 2002; 69: 1-13.
71. Latha M. Santhakumaran, Thresia Thomasand T.J. Thomas. Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropyleneimine dendrimers. Nucleic Acids Research 2004; 32: 2102-12.
72. Schatzlein AG, Zinselmeyer, BH, Elouzi A, Dufes C, Chim YT, Roberts CJ, et al. Preferential liver gene expression with polypropylenimine dendrimers. J Control Release 2005; 101: 247-58.
73. Merdan T, Kopecek J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev 2002; 54: 715-58.
74. Mah C, Byrne BJ, Flotte TR. Virus-based gene delivery systems. Clin Pharmacokinet 2002; 41: 901-11.
75. Lotze MT, Kost TA. Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther 2002; 9: 692-9.
76. Hwang SJ, Davis ME. Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration. Curr Opin Mol Ther 2001; 3: 183-91.
77. Favre D, Provost N, Blouin V, Blancho G, Cherel Y, Salvetti A, et al. Immediate and long-term safety of recombinant adenoassociated virus injection into the nonhuman primate muscle. Mol Ther 2001; 4: 559-66.
78. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40.
79. Timme TL, Hall SJ, Barrios R, Woo SLC, AguilarCordova E, Thompson TC. Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice. Cancer Gene Ther 1998; 5: 74-82.
80. Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148-58.
81. LeHoux JG, Grondin F. Some effects of chitosan on liver function in the rat. Endocrinology 1993; 132: 1078-84.
82. Zauner W, Ogris M, Wagner E. Polylysine-based transfection systems utilizing receptor-mediated delivery. Adv Drug Deliv Rev 1998; 30: 97-113.
83. Behr JP. Synthetic gene-transfer vectors. Acc Chem Res 1993; 26: 274-8.
84. Ledley FD. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995; 6: 1129-44.
85. Wolfert MA, Schacht EH, Toncheva V, Ulbrich K. Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum Gene Ther 1996; 7: 2123-33.
86. Florea BI, Meaney C, Junginger HE, Borchard G. Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. AAPS PharmSci 2002; 4: E12.
87. Akinc A, Langer R. Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking. Biotechnol Bioengg 2002; 78: 503-8.
88. Mumper RJ, Klakamp SL. Polymeric gene delivery systems for in vivo gene therapy. Drug Targeting and Delivery (Advanced Gene Delivery) 1999; 10:143-73.
89. Ward CM, Pechar M, Oupicky D, Ulbrich K, Seymour LW. Modification of PLL/ DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo. J Gene Med 2002; 4: 536-47.
90. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000; 18: 33-7.
91. Hughes MD, Hussain M, Nawaz Q, Sayyed P, Akhtar S. The cellular delivery of antisense oligonucleotides and ribozymes. Drug Discov Today 2001; 6: 303-15.
92. Gitsov I, Lambrych KR. In: Arshady R Ed, Dendrimers, Assemblies, Nanocomposites, Citus Books, London 2002; 5: 31-68.
93. Eichman JD Jr, Bielinska AU Jr, Kukowska-Latallo JF Jr, Baker JR Jr. The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharm Sci Technol Today 2000; 3: 232-45.
94. Bielinska AU, Chen CL, Johnson J, Baker JR. Complexing with Polyamidoamine Dendrimers: Implications for Transfection. Bioconjugate Chem 1999; 10: 843-50.
95. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A Versatile Vector for Gene and Oligonucleotide Transfer into Cells in Culture and in vivo: Polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-301.
96. Choi JS, Joo DK, Kim CH, Kim K, Park JS. Synthesis of a Barbelllike Triblock Copolymer, Poly (L-lysine) Dendrimer-blockpoly(ethylene glycol)-block-Poly(L-lysine) Dendrimer, and Its Self-Assembly with Plasmid DNA. J Am Chem Soc 2000; 122: 474-80.
97. Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci USA 1996; 93: 12349-54.
98. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, et al. Sterically stabilized liposomes: improvement in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991; 88: 11460-4.
99. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/ transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
100. Kichler A, Chillon M, Leboernge C, Danos O, Frisch B. Intranasal gene delivery with polyethyleneimine-PEG conjugate. J Control Release 2002; 81: 379-88.
101. Kren BT, Bandyopadhyay P, Steer CJ. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 1998; 4: 285-90.
102. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 1996; 3: 1074-80.
103. Goula D, Remy JS, Erbacher P, Wasowicz M, Levi G, Abdallah B, et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998; 5: 712-7.
104. Kirchler A, Behr JP, Erbacher P, Huang L, Hung MC, Wagner E (Eds.). Non-viral vector for gene therapy, Academic Press, San Diago, CA 1999: 191-06.
105. Goula D, Benoist C, Mantero S, Merlo G, Levi G, Demeneix BA. Polyethyleneimine-based intravenous delivery of transgene to mouse lung. Gene Ther 1998; 5: 1291-5.
106. Liu F, Huang L. Development of non-viral vectors for systemic gene delivery. J Control Release 2002; 78: 259-66.
107. Bragonnzi A, Dina G, Villa A, Calori G, Biffi A, Bordignon C, et al. Conese M. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 2000; 7: 1753-60.
108. Nguyen HK. Evaluation of polyether-polyethylenimine graft copolymers as gene transfer agents. Gene Ther 2000; 7: 126-38.
109. Katayose S, Kataoka K. Water-Soluble Polyion Complex Associates of DNA and Poly(ethylene glycol)-Poly(L-lysine) Block Copolymer. Bioconjugate Chem 1997; 8: 702-7.
110. Choi JS, Lee EJ, Choi YH, Jeong YJ, Park JS. Poly(ethylene glycol)-block-poly(L-lysine) Dendrimer: Novel Linear Polymer/Dendrimer Block Copolymer Forming a Spherical Water-Soluble Polyionic Complex with DNA. Bioconjugate Chem 1999; 10: 62-5.
111. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Weish MJ. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997-9007.
112. Segura T, Shea LD. Material for non viral gene delivery. Annu Rev Mater Res 2001; 31: 25-46.
113. Mannisto M, Vanderkerken S, Toncheva V, Elomaa M, Ruponen M, Schacht E, et al. Structure-activity relationships of Poly(L-lysine): effects of PEGylation and molecular shape on physiochemical and biological properties in gene delivery. J Control Release 2002; 83: 169-82.
114. Mao S, Neu M, Germershaus O, Merkel O, Sitterberg J, Bakowsky U, Kissel T. Influence of Polyethylene Glycol chain length on the physiochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. Bioconjugate chem 2006; 17: 1209-18.
115. Kirchler A, Leborgne C, Coeytaux E, Danos O. Polyethyleniminemediated gene delivery: a mechanistic study J Gene Med 2001; 3: 135-44.
116. Tang MX, Redemann CT, Szoka FC. In vitro Gene Delivery by Degraded Polyamidoamine Dendrimers. Bioconjugate Chem 1996; 7: 703-14.
117. Bhadra D, Yadav AK, Bhadra S, Jain NK. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm 2005; 295: 221-33.
118. Jansen JFGA. Encapsulation of guest molecules into a dendritic box. Science 1994; 266: 1226-9.
119. Raduchel B, Schmitt H, Willich J Ebert, Frezel T, Misselwitz B, Weinmann HJ. Synthesis and characterization of novel dendrimer based gadolinium complexes as MRI contrast agent for vascular system. Poly Mate Sci Engg (Am Chem Soc) 1998; 79: 516-7.
120. Roy R, Recent developments in the rational design of multivalent glycoconjugates. Top Curr Chem 1997; 187: 241-74.
121. Gitsov I, Wooley KL, Frechet JMJ. Novel polyether copolymers consisting of linear and dendritic blocks. Angew Chem Int Ed Engl 1992; 31:1200-2.
122. Bhadra D, Bhadra S, Jain NK. PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate. Pharm Res 2006; 23: 623-33.
123. Yang H, Lopina ST. In vitro enzymatic stability of dendritic peptides. J Biomed Mater Res A 2006; 76: 398-407.
124. Ihre HR, Padilla De Jesus OL, Szoka FC Jr, Frechet JMJ. Polyester Dendritic Systems for Drug Delivery Applications: Design, Synthesis, and Characterization. Bioconjugate Chem 2002; 13: 443-52.
125. Vijayaraj Kumar P, Agashe H, Dutta T, Jain N K. PEGylated Dendritic Architecture for Development of a Prolonged Drug Delivery System for an Antitubercular Drug. Curr Drug Del 2006; article in press.
126. Wiwattanapatapee R, Carreno-Gomez B, Malik N, Duncan R. Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system. Pharm Res 2000; 17: 991-8.
127. Jevprasesphant R, Penny J, Attwood, D, D'Emanuele A. Transport of dendrimer nanocarriers through epithelial cells via the transcellular route. J Control Release 2004; 97: 259-67.
128. El-Sayed M, Rhodes CA, Ginski M, Ghandehari H. Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int J Pharm 2003; 265: 151-7.
129. Xyloyannis M, Padilla De Jesus OL, Frechet JMJ, Duncan R. PEGdendron architecture influences endocytic capture and intracellular trafficking. Proc Int Symp Controll Rel Bioact Mater 2003; 30: 149.
130. Paleos C M, Tsiourvas D, Sideratou Z, Tziveleka L, Acid- and salt-triggered multifunctional poly(propylene imine) dendrimer as a prospective drug delivery system. Biomacromolecules 2004; 5: 524-9.
131. Berthezene Y, Vexler V, Price DC, Wisner-Dupon J, Moseley ME, Aicher, KP, et al. Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40. Invest Radiol 1992; 27: 346-51.
132. Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, et al. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 1994; 31:1-8.
133. Bourne MW, Margerun L, Hylton N, Campion B, Lai JJ, Derugin N, et al. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body. J Magn Reson Imaging 1996; 6: 305-10.
134. Bryant Jr LH, Brechbiel MW, Wu C, Bulte JW, Herynek V, Frank JA. Synthesis and relaxometry of high-generation (G 5 5, 7, 9, and 10) PAMAM™ dendrimer-DOTA-gadolinium chelates. J Magn Reson Imaging 1999; 9: 348-52.
135. Kobayashi H, Sato N, Hiraga A, Saga T, Nakamoto Y, Ueda H, et al. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with references to their pharmacokinetic properties. Magn Reson Med 2001; 45: 454-60.
136. Kabayashi H, Kamamoto S, Saga T, Sato N, Hiraga A, Ishimori T, et al. Positive Effects of Polyethylene Glycol Conjugation to Generation-4 Polyamidoamine Dendrimers as Macromolecular MR Contrast Agents; Magn Reson Med 2001; 46: 781-8.
137. Astruc D, Chardac F. Dendritic Catalysts and Dendrimers in Catalysis. Chem Rev 2001; 101: 2991-3024.
138. Oosterom GE, Reek JNH, Kamer PCJ, van Leeuwen PWNM. Transition Metal Catalysis Using Functionalized Dendrimers. Angew Chem Int Ed 2001; 40: 1828-49.
139. Yoon HC, Hong MY, Kim HS. Functionalization of a Poly (amidoamine) Dendrimer with Ferrocenyls and Its Application to the Construction of a Reagentless Enzyme Electrode. Anal Chem 2000; 72: 4420-7.
140. Yoon HC, Hong MY, Kim HS, Affinity Biosensor for Avidin Using a Double Functionalized Dendrimer Monolayer on a Gold Electrode. Anal Biochem 2000; 282: 121-8.
141. 4 anion. Chem Commun 2003: 464-5.
142. Fabris P, Barnes E, Tositti G, Giordani MT, Grasso A, De Lalla F. Therapy of chronic hepatitis C virus infection in HIV co-infected people. Curr Pharm Des 2004; 10(17): 2111-22.
143. Molineux G. The design and development of pegfilgrastim (PEGrmetHuG-CSF, Neulasta). Curr Pharm Des 2004; 10(11): 1235-44.
144. Santin AD, Bellone S, Roman JJ, Burnett A, Cannon MJ, Pecorelli S. Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy. Curr Pharm Des 2005; 11(27): 3485-500.